Rigel Pharmaceuticals (RIGL) EBT Margin (QoQ) (2010 - 2026)
Rigel Pharmaceuticals (RIGL) EBT Margin (QoQ) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - |
| 10 | Rigel Pharmaceuticals | 674.25 Mn | 527.57 Mn | 54.21 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1,272.00 |
| Dec 31, 2025 | -722.00 |
| Sep 30, 2025 | -1,923.00 |
| Jun 30, 2025 | 3,740.00 |
| Mar 31, 2025 | -485.00 |
| Dec 31, 2024 | 397.00 |
| Sep 30, 2024 | 2,525.00 |
| Jun 30, 2024 | 2,513.00 |
| Mar 31, 2024 | -2,795.00 |
| Dec 31, 2023 | 2,026.00 |
| Sep 30, 2023 | 432.00 |
| Jun 30, 2023 | 2,881.00 |
| Mar 31, 2023 | -5,609.00 |
| Dec 31, 2022 | 8,768.00 |
| Sep 30, 2022 | -3,970.00 |
| Jun 30, 2022 | 11,875.00 |
| Mar 31, 2022 | -5,277.00 |
| Dec 31, 2021 | -1,334.00 |
| Sep 30, 2021 | -4,158.00 |
| Jun 30, 2021 | -10,725.00 |